The EncircleRx^SM portfolio is part of our GLP-1 Management Suite of Solutions that helps plan sponsors reduce costs and enhance outcomes. EncircleRx: Cardiodiabesity gives clients optionality and predictability in managing cardiodiabesity—obesity, diabetes and cardiovascular disease—with the first-ever GLP-1 financial guarantee from a PBM. 

Obesity, diabetes, and cardiovascular disease are on the rise. Left unmanaged, these comorbid conditions can cause medical expenses to skyrocket and lead to poor health outcomes, inclusive of disability, and death.

Our study, which is based on 495,180 adults with diagnosed ADHD, uncovered that social and economic factors impact the prevalence of ADHD treatment.

Dr. Eric Weil, chief medical officer of MDLIVE by Evernorth, has been able to blend his dream of being a doctor with his passion for health care innovation, helping to bring quality health care to millions of Americans in the comfort of their own homes.

We believe robust pharmacy networks are critical to ensuring access for Medicare customers and that individual pharmacists deserve the opportunity to make the decision that’s best for their business.

Accelerating access to innovative therapies by connecting patients to clinical research. Our data-driven approach helps sponsors recruit faster, engage diverse populations and improve outcomes across the healthcare ecosystem.